GSH [GUANGSHEN RAILWAY CO] SC 13G/A: (Original Filing)

[for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose ("Act") or otherwise subject to]

By | 2016-03-16T21:34:01+00:00 June 8th, 2012|Categories: Chinese Stocks, GSH, SEC Original|Tags: , , , , , |0 Comments

NQ [NQ Mobile] RW: (Original Filing)

[* * * Very truly yours, Henry Yu Lin Chairman and Co-Chief Executive Officer cc: Omar Sharif Khan, Director and Co-Chief Executive Officer, NQ Mobile Inc. Suhai Ji, Chief Financial Officer, NQ Mobile Inc. Z. Julie Gao, Skadden, Arps, Slate, Meagher & Flom LLP David J. Johnson, Jr., Esq., O’Melveny & Myers LLP David J. Roberts, Esq., O’Melveny & Myers]

By | 2016-03-11T10:01:58+00:00 June 7th, 2012|Categories: Chinese Stocks, NQ, SEC Original|Tags: , , , , , |0 Comments

HNP [HUANENG POWER INTERNATIONAL] 6-K: (Original Filing)

[This Form 6-K consists of: ISSUE OF SUPER SHORT-TERM DEBENTURES As resolved at the 2010 Annual General Meeting of Huaneng Power International, Inc. (the "Company"), the Company may apply to the National Association of Financial Market Institutional Investors for the quota to issue super short-term debentures with a principal amount of not exceeding RMB20 billion (to be issued with such]

By | 2016-03-30T13:46:17+00:00 June 7th, 2012|Categories: Chinese Stocks, HNP, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical to Acquire Controlling Stake in Dragonbio’s Orthopedics Business for US$35.5 million SHENZHEN, China, June 6, 2012 /PRNewswire-Asia-FirstCall/ — Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire a controlling stake of Wuhan Dragonbio Surgical Implant Co., Ltd. (“Dragonbio”), a domestic medical orthopedic products provider that]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical to Acquirentrolling Stake in Dragonbios Orthopedics Business for US$35.5 million STYLE="font-family:Times New Roman" SIZE="2"> STYLE="font-family:Times New Roman" SIZE="2">SHENZHEN, China, June6, 2012 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitivereement to acquire antrolling stake of Wuhan Dragonbio Surgical Implant (Dragonbio), a domestic]

Skip to toolbar